Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Triple combination therapy for cystic fibrosis linked to plunging hospitalizations

Publish date:: November 10, 2020

Key clinical point: Triple therapy may dramatically reduce hospitalization costs.

Major finding: No patients on triple therapy were hospitalized during the study period.

Study details: Retrospective analysis (n = 47).

Disclosures: Dr. Walter, Dr. Giusti, and Dr. Perkins have no relevant financial disclosures.

Citation:

Walter E et al. NACFC 2020. Abstract 795.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

Osteoporosis prevalence in PsA similar to general population,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

DOACs look safe in elective endoscopic procedures,

Anorexia and diarrhea top list of GI symptoms in COVID-19 patients,

Must Reads in Pulmonology

E-cigarette use tied to increased COPD, asthma risk,

Obesity, hypoxia predict severity in children with COVID-19,

Telehealth finds acceptance among patients with CF, clinicians,

COVID-19 burdens follow patients after discharge,

Poverty raises depression risk in patients with cystic fibrosis,

All Specialties